PARIS (Reuters) – Vaccines company Valneva said on Friday that it had completed a regulatory submission step with the United States Food & Drug Administration (FDA) for its single-shot chikungunya …
valneva
-
-
By Natalie Grover (Reuters) -Valneva lost nearly a fifth of its value on Monday after the French drugmaker said its COVID-19 vaccine agreement with the European Commission was likely to …
-
PARIS – French vaccines company Valneva, which is aiming to get European approval for its COVID-19 vaccine product, said it had secured new financing with U.S.-based healthcare investment firms Deerfield …
-
– French vaccine developer Valneva targets increasing its revenues year-on-year by up to 70% thanks to a boost from its COVID-19 vaccine candidate, it said on Thursday. The company sees …
-
PARIS -French vaccines company Valneva’s share price jumped more than 20% on Wednesday after it won European Commission approval for a deal under which it would supply up to 60 …